Literature DB >> 31312207

Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades.

Hao Chen1,2, Wei Chong3, Qian Wu4, Yueliang Yao5, Min Mao6, Xin Wang7.   

Abstract

[This corrects the article DOI: 10.3389/fimmu.2019.01113.].

Entities:  

Keywords:  LRP1B; NSCLC; immunotherapy; melanoma; mutation signatures; tumor mutation burden

Year:  2019        PMID: 31312207      PMCID: PMC6614515          DOI: 10.3389/fimmu.2019.01523

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


In the published article, there was an error in affiliation “1.” Instead of “Shandong Academy of Clinical Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China,” it should be “Clinical Epidemiology Unit, Qilu Hospital of Shandong University, Jinan, China.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
  2 in total

1.  Effects of LRP1B Regulated by HSF1 on Lipid Metabolism in Hepatocellular Carcinoma.

Authors:  Miaomiao Li; Juntao Hu; Riming Jin; Hongxia Cheng; Huaping Chen; Limin Li; Kun Guo
Journal:  J Hepatocell Carcinoma       Date:  2020-12-08

2.  Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer.

Authors:  Sizhe Hu; Xiaokang Zhao; Feng Qian; Cancan Jin; Kaishun Hou
Journal:  Comput Math Methods Med       Date:  2021-09-21       Impact factor: 2.238

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.